Women's Health.Reimagined.
Affordable, rapid, and accurate diagnostics designed specifically for women — bringing laboratory-grade precision to the point of need.
Smart Diagnostics. Stronger Women.
Today's fertility tests stop at yes or no.
Hormones move on a curve, not a switch. Yet the tools women rely on flatten that signal — and the precise, trended data that informs real reproductive decisions stays locked inside the lab.
A single line gives a yes/no answer with no measurement and no trend.
Quantitative hormone panels are costly and often out of reach.
Turnaround breaks the timing that fertility decisions depend on.
Without serial, quantitative data, patterns like PCOS go unseen.
Laboratory precision, in your hand.
SyncHer OvuWise delivers quantitative hormone measurement in a portable, affordable format — turning a single-use answer into an actionable health signal.
Quantitative readout
An exact LH concentration, not a line — so trends become visible across a cycle.
Results in under 5 minutes
Decisions can be made in the moment they matter, at home or in clinic.
Accessible anywhere
Paper-based disposable strips and a reusable reader bring testing beyond the lab.
SyncHer OvuWise™
A quantitative luteinizing hormone monitoring platform for ovulation prediction, fertility tracking, PCOS monitoring, ART cycle management, and hormonal trend analysis.
What makes it different
Every advantage points the same direction: more signal, fewer barriers.
A diagnostics platform built for women.
One sensing platform, designed to extend across the conditions where women's health is most underserved.
Reproductive Health
Quantitative LH monitoring for fertility, ovulation, PCOS, and ART cycle management.
The science under the surface.
An electrochemical sensing stack that combines advanced nanomaterials with paper microfluidics to deliver lab-grade detection at the point of care.
Electrochemical biosensors
Direct, quantitative signal transduction from sample to digital readout.
Pd–Ti₃C₂ MXene sensing
2D nanomaterials that amplify sensitivity and lower the detection limit.
Paper microfluidics
Capillary-driven fluid handling — no pumps, low cost, single use.
Carbon screen-printed electrodes
Mass-manufacturable sensing surfaces engineered for reproducibility.
Nanomaterial-enabled sensing
Surface chemistry tuned for selective capture of target hormones.
Digital health integration
Portable analytics and trend tracking, ready for connected care.
Measured, not marketed.
Performance demonstrated through prototype validation studies, including evaluation across patient samples at SGPGI, Lucknow.
From prototype to clinic.
A deep-tech company advancing through validated, fundable stages — addressing infertility, enabling decentralized diagnostics, and reducing healthcare disparities for women.
HerNostics Pvt. Ltd.
Founded to build female-specific point-of-care diagnostics.
Functional LH diagnostic built
Reaching TRL 4–5 technology maturity.
Patent application filed
Application No. 202511085669.
Clinical validation initiated
Evaluated across 50+ patient samples at SGPGI, Lucknow.
₹7 lakh grant from MeitY
Supporting validation and scale-up.
Manufacturing & market entry
Scaling production and deployment with partners.
Founded by researchers, not generalists.
Dr. Ashish Mathur
Professor and researcher in biosensors and point-of-care diagnostics.
- 150+ publications
- H-index 32
- 31+ patents filed
Dr. Shikha Wadhwa
18+ years in materials chemistry and sensing technologies.
- 68 publications
- H-index 25
- Materials & sensing
Built to scale through partnership.
We're seeking collaborators across the diagnostics value chain to accelerate validation, manufacturing, and deployment.
Building the future of women's diagnostics.
HerNostics is actively seeking strategic partners and investors to accelerate clinical validation, manufacturing scale-up, and market deployment.